BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• 

  Deals

  Is Gilead Making a Play for Forty Seven Inc.?

  Shares of Forty Seven Inc. were up in premarket trading on rumors that Gilead Sciences has approached the company about a potential partnership or acquisition.

  February 28, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Alnylam Taps Former Sanofi CEO Olivier Brandicourt for Board of Directors

  Brandicourt stepped down from his role as chief executive officer of Sanofi last year.

  February 28, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Verastem Shifts Resources to Focus on Developing Solid Tumor Drug

  The company expects to decrease its operating expenses by about 40% this year compared to 2019.

  February 28, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Bio NC

  Clinical Catch-Up: February 24-28

  The month of February ended with a flurry of clinical trial announcements. Here’s a look.

  February 28, 2020

   · 

  8 min read

   · 

  Mark Terry
• 

  Business

  Biogen and Sangamo Ink $2.7 Billion+ Neurodegeneration Deal

  Biogen and Sangamo Therapeutics announced a broad global licensing collaboration deal to develop and commercialize several compounds for a range of neurological and neuromuscular diseases.

  February 28, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Coronavirus Update: Death Toll Increases, U.S. Government Takes Action

  The novel coronavirus that causes the disease COVID-19 continues to spread and has now been diagnosed in more than 50 countries.

  February 28, 2020

   · 

  1 min read

   · 

  Mark Terry
• 

  Deals

  Despite Market Drama, Passage Bio Launches $216 Million IPO

  The company offered 12 million shares at $18 per share and raised $216 million, 72% more than originally expected.

  February 28, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Researchers Link a Common Gut Bacteria to Colorectal Cancer Mutations

  It marks the first time researchers have been able to establish a direct link between microbes living in the body and genetic alterations that can drive cancer and could lead to new treatments for colorectal cancer.

  February 28, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  How to Create an Effective Resume Focal Point

  Two effective focal components – deployed separately or together – are the resume headline and resume branding statement.

  February 28, 2020

   · 

  4 min read

   · 

  Katharine Hansen, PhD
• New Research Uncovers the Toll Rare Diseases Take on Relationships

  According to a new survey from rare disease company Sobi, 28 per cent of people living with a rare condition, and their caregivers, say the disease has caused a relationship to end.

  February 28, 2020

   · 

  3 min read